Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study

BA (Ben) van Hout; L Bowman; DJ Zelinger; Maarten Simoons

Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study

BA (Ben) van Hout, L Bowman, DJ Zelinger, Maarten Simoons

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	59-66
Number of pages	8
Journal	European Heart Journal
Volume	19
Publication status	Published - 1998

Cite this

@article{496d86bf3b08439a86a17e985b9cc54e,

title = "Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study",

author = "{van Hout}, {BA (Ben)} and L Bowman and DJ Zelinger and Maarten Simoons",

note = "geen doi",

year = "1998",

language = "Undefined/Unknown",

volume = "19",

pages = "59--66",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Costs and effects in therapy for acute coranary syndromes: The case of abciximab in high- risk patients undergoing percutaneous translumial coranary angioplasty in the EPIC study

AU - van Hout, BA (Ben)

AU - Bowman, L

AU - Zelinger, DJ

AU - Simoons, Maarten

N1 - geen doi

PY - 1998

Y1 - 1998

M3 - Article

VL - 19

SP - 59

EP - 66

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

ER -